Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Correction: Activation of Notch Signaling Is Required for Cholangiocarcinoma Progression and Is Enhanced by Inactivation of p53 In Vivo.

El Khatib M, Bozko P, Palagani V, Malek NP, Wilkens L, Plentz RR.

PLoS One. 2018 Nov 1;13(11):e0206953. doi: 10.1371/journal.pone.0206953. eCollection 2018.

2.

Prioritizing problems in and solutions to homecare safety of people with dementia: supporting carers, streamlining care.

Tudor Car L, El-Khatib M, Perneczky R, Papachristou N, Atun R, Rudan I, Car J, Vincent C, Majeed A.

BMC Geriatr. 2017 Jan 19;17(1):26. doi: 10.1186/s12877-017-0415-6.

3.

Preventing delayed diagnosis of cancer: clinicians' views on main problems and solutions.

Car LT, Papachristou N, Urch C, Majeed A, El-Khatib M, Aylin P, Atun R, Car J, Vincent C.

J Glob Health. 2016 Dec;6(2):020901. doi: 10.7189/jogh.06.020901.

4.

Identification of priorities for improvement of medication safety in primary care: a PRIORITIZE study.

Tudor Car L, Papachristou N, Gallagher J, Samra R, Wazny K, El-Khatib M, Bull A, Majeed A, Aylin P, Atun R, Rudan I, Car J, Bell H, Vincent C, Franklin BD.

BMC Fam Pract. 2016 Nov 16;17(1):160.

5.

Correction: Capsaicin Treatment Attenuates Cholangiocarcinoma Carcinogenesis.

Wutka A, Palagani V, Barat S, Chen X, El Khatib M, Götze J, Belahmer H, Zender S, Bozko P, Malek NP, Plentz RR.

PLoS One. 2016 Sep 20;11(9):e0162673. doi: 10.1371/journal.pone.0162673. eCollection 2016.

6.

Clinician-identified problems and solutions for delayed diagnosis in primary care: a PRIORITIZE study.

Tudor Car L, Papachristou N, Bull A, Majeed A, Gallagher J, El-Khatib M, Aylin P, Rudan I, Atun R, Car J, Vincent C.

BMC Fam Pract. 2016 Sep 9;17:131. doi: 10.1186/s12875-016-0530-z.

7.

A Critical Role for Notch Signaling in the Formation of Cholangiocellular Carcinomas.

Zender S, Nickeleit I, Wuestefeld T, Sörensen I, Dauch D, Bozko P, El-Khatib M, Geffers R, Bektas H, Manns MP, Gossler A, Wilkens L, Plentz R, Zender L, Malek NP.

Cancer Cell. 2016 Aug 8;30(2):353-356. doi: 10.1016/j.ccell.2016.07.005. Epub 2016 Aug 8. No abstract available.

8.

Capsaicin treatment attenuates cholangiocarcinoma carcinogenesis.

Wutka A, Palagani V, Barat S, Chen X, El Khatib M, Götze J, Belahmer H, Zender S, Bozko P, Malek NP, Plentz RR.

PLoS One. 2014 Apr 18;9(4):e95605. doi: 10.1371/journal.pone.0095605. eCollection 2014. Erratum in: PLoS One. 2016;11(9):e0162673.

9.

Combined inhibition of Notch and JAK/STAT is superior to monotherapies and impairs pancreatic cancer progression.

Palagani V, Bozko P, El Khatib M, Belahmer H, Giese N, Sipos B, Malek NP, Plentz RR.

Carcinogenesis. 2014 Apr;35(4):859-66. doi: 10.1093/carcin/bgt394. Epub 2013 Nov 30.

PMID:
24293409
10.

Activation of Notch signaling is required for cholangiocarcinoma progression and is enhanced by inactivation of p53 in vivo.

El Khatib M, Bozko P, Palagani V, Malek NP, Wilkens L, Plentz RR.

PLoS One. 2013 Oct 30;8(10):e77433. doi: 10.1371/journal.pone.0077433. eCollection 2013. Erratum in: PLoS One. 2018 Nov 1;13(11):e0206953.

11.

A critical role for notch signaling in the formation of cholangiocellular carcinomas.

Zender S, Nickeleit I, Wuestefeld T, Sörensen I, Dauch D, Bozko P, El-Khatib M, Geffers R, Bektas H, Manns MP, Gossler A, Wilkens L, Plentz R, Zender L, Malek NP.

Cancer Cell. 2013 Jun 10;23(6):784-95. doi: 10.1016/j.ccr.2013.04.019. Epub 2013 May 30. Erratum in: Cancer Cell. 2016 Aug 8;30(2):353-356.

12.

Inhibition of hedgehog signaling attenuates carcinogenesis in vitro and increases necrosis of cholangiocellular carcinoma.

El Khatib M, Kalnytska A, Palagani V, Kossatz U, Manns MP, Malek NP, Wilkens L, Plentz RR.

Hepatology. 2013 Mar;57(3):1035-45. doi: 10.1002/hep.26147. Epub 2013 Jan 25. Erratum in: Hepatology. 2014 Aug;60(2):771.

PMID:
23172661
13.

Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX.

Palagani V, El Khatib M, Kossatz U, Bozko P, Müller MR, Manns MP, Krech T, Malek NP, Plentz RR.

PLoS One. 2012;7(10):e46514. doi: 10.1371/journal.pone.0046514. Epub 2012 Oct 19.

14.

Decrease of CD44-positive cells correlates with tumor response to chemotherapy in patients with gastrointestinal cancer.

Palagani V, El Khatib M, Krech T, Manns MP, Malek NP, Plentz RR.

Anticancer Res. 2012 May;32(5):1747-55.

PMID:
22593456
15.

Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21.

El-Khatib M, Geara F, Haddadin MJ, Gali-Muhtasib H.

Radiat Oncol. 2010 Nov 15;5:107. doi: 10.1186/1748-717X-5-107.

16.

Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers.

Al-Kassas RS, El-Khatib MM.

Drug Deliv. 2009 Apr;16(3):145-52. doi: 10.1080/10717540802689008.

PMID:
19514974
17.

Thermally reversible in situ gelling carbamazepine liquid suppository.

El-Kamel A, El-Khatib M.

Drug Deliv. 2006 Mar-Apr;13(2):143-8.

PMID:
16423803

Supplemental Content

Loading ...
Support Center